Mangafodipir as a cytoprotective adjunct to chemotherapy--a case report

Acta Oncol. 2009;48(4):633-5. doi: 10.1080/02841860802680427.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chemotherapy, Adjuvant
  • Cholangitis, Sclerosing / complications
  • Colectomy*
  • Colonic Neoplasms / blood
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / etiology
  • Colonic Neoplasms / surgery
  • Crohn Disease / complications
  • Cytoprotection*
  • Edetic Acid / administration & dosage
  • Edetic Acid / analogs & derivatives*
  • Edetic Acid / therapeutic use
  • Fluorouracil / administration & dosage
  • Humans
  • Leucovorin / administration & dosage
  • Male
  • Palliative Care / methods
  • Pyridoxal Phosphate / administration & dosage
  • Pyridoxal Phosphate / analogs & derivatives*
  • Pyridoxal Phosphate / therapeutic use
  • Young Adult

Substances

  • Pyridoxal Phosphate
  • Edetic Acid
  • N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
  • Leucovorin
  • Fluorouracil